Research, Industry, Medical and Scientific News

Share

Below you will find news and press releases from industry, government, and academia regarding product developments and medical/scientific research news.

Bacteria

How Urobiome Composition Impacts Urinary Incontinence

A urobiome community type with fewer Lactobacilli and more diverse bacteria is associated with more severe urinary incontinence (UI) episodes vs a type with high predominance of a single genus, Lactobacillus, according to a recent study published in the American Journal of Obstetrics & Gynecology. Bacteria has been categorized into various niches, including the bladder niche and adjacent vaginal niche in women. Sequencing methods allow for urothelial and squamous intracellular bacteria to be identified. These bacteria may serve as reservoirs for chronic conditions such as urinary tract infection (UTI). Read more.

Source: Contemporary OB/GYN, March 19, 2024

clinical medical

Affluent Medical Touts First Implant of Artificial Urinary Sphincter

Affluent Medical today announced the successful first-in-human implant of its minimally invasive urinary incontinence treatment device.  Dr. Roman Zachoval completed the first implant of Artus, an artificial urinary sphincter. Zachoval, head of urology at Thomayer University Hospital in Prague, implanted Artus in a 68-year-old male patient with severe urinary incontinence. Read more.

Source: Mass Device, March 12, 2024

VCU Health Leads Clinical Trial For New treatment To Help People With Bowel Control Problems

A research team at VCU Health is leading a clinical trial to assess a novel treatment for fecal incontinence or sudden loss of control over bowel movements. The therapy involves implanting a bioengineered sphincter derived from the patient’s native cells to help them regain control of their bowels.  The implantation surgery for the clinical trial is being led by Jaime Bohl, M.D., an associate professor in the Department of Surgery and chief of the Division of Colon and Rectal Surgery at Virginia Commonwealth University’s School of Medicine. Read more.

Source: VCU Health, February 28, 2024

nerve cells

Amber Therapeutics Announces Positive Preliminary Results From Its First-In-Human Investigation of Amber-UI, Its New Adaptive Implanted Pudendal Neuromodulation System for Urinary Incontinence

Amber Therapeutics (‘Amber’ or the ‘Company’), an innovative medical technology company developing next-generation, intelligent bioelectrical therapies to transform clinical outcomes in patients with functional disorders of the peripheral nervous system, announces the presentation of the first data from its AURA-2 (Augmenting Urinary Reflex Activity) first-in-human study evaluating Amber-UI.  Amber-UI is the first fully implantable closed-loop bioelectrical therapy in clinical development for urinary incontinence (UI), which is made possible by being able to access and target the pudendal nerve – the nerve that directly controls continence – through a novel, minimally invasive surgical procedure. Read more.

Source: WWLP.com, February 27, 2024

nurse and patient

Pelvital Announces Landmark Study Demonstrating Efficacy of Flyte® Device in Treating Stress Urinary Incontinence

Pelvital, the women’s health MedTech company on a mission to transform the standard of care for urinary incontinence, announced today the publication of its landmark paper “Randomized trial of mechanotherapy for the treatment of stress urinary incontinence in women” in the peer-reviewed journal Therapeutic Advances in Urology. The paper presents evidence of the efficacy of Pelvital’s novel, FDA-cleared device, Flyte, for the treatment of stress urinary incontinence (SUI) and weakened pelvic floor muscles, with results comparable to surgical intervention. Read more.

Source: PRNewsire, February 21, 2024

UroMems Announces Results of First-Ever Smart Artificial Urinary Sphincter Implant in Female Patient to Treat Stress Urinary Incontinence

UroMems, a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it has successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI. This milestone indicates a new era for millions of women suffering from SUI, and signals an exciting transition for surgeons treating SUI not only in France, where the female patient was treated, but also across Europe and the U.S. Read more.

Source: PRNewswire, February 14, 2024

Dr. Larissa Rodriguez Wins Victor A. Politano Award from American Urological Association

Dr. Larissa V. Rodriguez, chair of the Department of Urology and the James J. Colt Professor of Urology at Weill Cornell Medicine and urologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, was named winner of the 2024 Victor A. Politano Award by the American Urological Association.  The award is presented annually to an individual for outstanding achievements in the field of urinary incontinence. Dr. Rodriguez is being honored for her work to advance the treatment of urinary incontinence through pioneering research and compassionate patient care. She will be recognized at the association’s annual meeting in San Antonio, Texas in May. Read more.

Source: Weill Cornell Medicine, February 8, 2024